Follow-The-Filings

Security · featured owners

AXSM Axsome Therapeutics Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 3 Owners
  • Max 0.5%
  • $5M
  • 1 new 2 add 1 exit

AXSM (Axsome Therapeutics Inc.) is held in 3 featured 13F books as of 2026 Q2. Torray Investment Partners is the largest tracked holder by portfolio weight (0.49%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.5% (Torray Investment Partners) · not free-float ownership

  1. Torray Investment Partners add 0.49%
  2. Polen Capital Management add 0.01%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Torray Investment Partners 2026 Q2 0.49% Add +1.0% 14,928 $4M history
Polen Capital Management 2026 Q2 0.01% Add +111.2% 4,468 $1M history
Ron Baron - Bamco Inc. (Baron Capital) 2026 Q2 <0.01% New <0.01% 3,000 $734K history
Farallon Capital Management exited 2026 Q2 last 2026 Q1 <0.01% Exit 0.00% 4,000 $676K history

3 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 11 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,8.01,9.01 Filing Doc
10-Q Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.07,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
10-Q Filing Doc
8-K 8.01,9.01 Filing Doc
DEFA14A Filing Doc
8-K 8.01,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 14 rows shown

Filed Form Detail Links
4 Period Sep 3, 2026 Filing Doc
4 Period Aug 5, 2026 Filing Doc
4 Period Jul 1, 2026 Filing Doc
4 Period Jun 10, 2026 Filing Doc
4 Period Jun 8, 2026 · 4 forms Filing Doc
4 Period Jun 5, 2026 · 2 forms Filing Doc
4 Period Jun 9, 2026 · 2 forms Filing Doc
4 Period Jun 5, 2026 · 2 forms Filing Doc
4 Period May 29, 2026 Filing Doc
4 Period May 4, 2026 Filing Doc
4 Period Apr 21, 2026 · 3 forms Filing Doc
4 Period Apr 22, 2026 Filing Doc
4 Period Apr 21, 2026 · 2 forms Filing Doc
4 Period Feb 26, 2026 · 3 forms Filing Doc

Updated 6 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $270.6M $385.69M $638.5M
Net income -$239.24M -$287.22M -$183.17M
Net margin * -88.4% -74.5% -28.7%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $504.26M $485.06M $588.99M
Total non-current assets * $83.97M $83.43M $100.82M
Total assets $588.24M $568.5M $689.8M
Total current liabilities $138.85M $230.1M $378.84M
Total non-current liabilities * $258.4M $281.38M $222.67M
Total equity $190.98M $57.02M $88.3M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$145.08M -$128.41M -$93.4M
Cash from investing -$582,000 -$270,000 -$480,000
Cash from financing $331.01M $57.84M $101.46M
Net change in cash $185.35M -$70.84M $7.58M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders